Apogee Therapeutics, Inc.

This early-stage study is testing a new combination of two drugs, APG777 and APG990, for adults with moderate-to-severe eczema (atopic dermatitis). The main goal is to see if the combination is safe and how the body handles it, comparing it directly to an existing approved drug c…

This is an early-stage study to check the safety and side effects of a new drug called APG777 in adults with mild-to-moderate asthma. About 31 participants will be randomly assigned to receive either the drug or a placebo (inactive substance) for a year. The main goal is to see h…

This study is testing an experimental injection called APG777 for people with moderate-to-severe eczema (atopic dermatitis). Researchers want to see if different doses of APG777 can safely reduce skin inflammation and itching better than a placebo. The trial will last up to 2 yea…